May 09, 2023 / 12:30PM GMT
Operator
Hello. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Q1 2023 Seres Therapeutics Earnings Conference Call. (Operator Instructions)
Dr. Carlo Tanzi, Investor Relations. You may begin.
Carlo Tanzi - Seres Therapeutics, Inc. - IR Officer
Thank you, and good morning. Our press release for the company's first quarter 2023 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found in the Investors and News section of the company's website. We will also be reviewing new SER-155 Phase Ib study results, and we have posted slides on our corporate website that will accompany our remarks.
I'd like to remind you that we will be making forward-looking statements, including the timing of commercial launch, the availability of VOWST, the commercial success of VOWST, the timing and results of clinical studies, the timing of additional clinical data, final study results, the ability for microbiome therapeutics to modulate for microbiome and
Q1 2023 Seres Therapeutics Inc Earnings Call Transcript
May 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers